Fibromyalgia affects an estimated 4 million Americans, or about 2% of the population
Fibromyalgia Treatment in La Crosse, WI: Relief for the Pain Nobody Else Can See
Fibromyalgia is a real, recognized neurological condition, not a diagnosis of exclusion or a psychological problem. IV ketamine therapy targets the central sensitization driving fibromyalgia pain at its neurological source, offering meaningful relief for patients who have cycled through medications without adequate results.
Your Pain Is Real. Your Exhaustion Is Real. And You Deserve Treatment That Takes Both Seriously.
Fibromyalgia affects an estimated 4 million Americans, roughly 2% of the population, with women diagnosed at significantly higher rates than men. It’s characterized by widespread musculoskeletal pain, fatigue, sleep disruption, and cognitive difficulties often called fibro fog. And it’s one of the most frequently dismissed, minimized, and misunderstood conditions in medicine.
The dismissal is both medically incorrect and deeply harmful. Fibromyalgia is now well-understood as a disorder of central pain processing: the brain and spinal cord amplify pain signals in a way that produces real, measurable pain from stimuli that wouldn’t cause pain in a person without the condition. It’s not imagined, and it’s not psychological. It’s neurological.
IV ketamine therapy targets the central sensitization mechanism driving fibromyalgia pain directly, intervening at the NMDA receptor level to interrupt the amplified pain signaling that defines the condition. At Relevate Ketafusion, we take fibromyalgia seriously and we treat it accordingly, right here in La Crosse.
Understanding Fibromyalgia: A Nervous System That's Turned the Volume Up Too High
Fibromyalgia is now classified as a central sensitization syndrome, a condition in which the central nervous system has become abnormally sensitive to pain, fatigue, and sensory input of all kinds. The nervous system’s pain-processing volume gets turned up and stays up, amplifying signals that would be manageable for most people into something overwhelming.
NMDA receptors play a key role in establishing and maintaining central sensitization. When these receptors are chronically overactivated, they lower the pain threshold throughout the body, increase sensitivity to touch, temperature, and pressure, and contribute to the fatigue and cognitive difficulties that accompany fibromyalgia pain. This is exactly why ketamine, one of the most potent NMDA receptor antagonists in clinical medicine, has direct relevance for fibromyalgia treatment.
It’s also worth addressing the skepticism some patients have about using a medication known for mental health treatment for a pain condition. Ketamine isn’t a psychiatric drug being applied off-label to pain. It’s an analgesic with a 50-year history of use in pain management, and its mechanism of action through NMDA receptor blockade is arguably more directly relevant to fibromyalgia than to any other chronic pain condition.
Hear from Those Who've Found Hope
Call us
(608) 518-3915Address
2309 State Road La Crosse, WI 54601
Working hours
Mon-Thu: 7:30 am - 7:30 pm
Fri-Sat: 7:30 am - 12:30 pm
Book Your Consultation
Fill out the form below, and we’ll contact you shortly.
Fibromyalgia Presentations and Related Conditions We Treat
Fibromyalgia rarely presents in isolation. It typically comes with a constellation of co-occurring conditions that share the same central sensitization mechanism. Ketamine therapy's ability to address the underlying neurological process makes it relevant across this entire spectrum.
Treatment-Resistant Fibromyalgia
When duloxetine, milnacipran, pregabalin, and other FDA-approved fibromyalgia medications haven't provided adequate relief, treatment-resistant fibromyalgia is the clinical picture. This is the population most likely to benefit from ketamine therapy's different mechanism. By targeting NMDA receptors rather than serotonin-norepinephrine reuptake, ketamine addresses the central sensitization process that these medications attempt to modulate indirectly.
Fibromyalgia with Depression
Depression is one of the most common co-occurring conditions in fibromyalgia, and the relationship is bidirectional: fibromyalgia pain worsens depression, and depression amplifies fibromyalgia pain. Standard fibromyalgia medications like duloxetine have some antidepressant effect, but for patients with significant treatment-resistant depression alongside fibromyalgia, ketamine therapy addresses both conditions simultaneously through its direct action on the glutamate system.
Fibromyalgia with Anxiety
Anxiety is extremely common in fibromyalgia, and like depression it amplifies the central sensitization driving the pain. Chronic pain patients are 2 to 3 times more likely to have an anxiety disorder, and the hyperarousal of anxiety keeps the nervous system in a heightened state that makes pain worse. Ketamine's rapid calming effect on overactive neural circuits can help reduce anxiety while simultaneously addressing the central pain amplification.
Fibromyalgia with Fatigue and Sleep Disturbance
Fatigue and non-restorative sleep are defining features of fibromyalgia, and they feed the pain cycle: poor sleep worsens central sensitization, which worsens pain, which disrupts sleep further. While ketamine therapy primarily targets the central pain processing component of fibromyalgia, meaningful pain reduction often produces downstream improvements in sleep quality and fatigue as the nervous system's overall burden decreases.
Fibromyalgia with Widespread Pain Sensitization
For patients whose fibromyalgia has produced widespread allodynia, pain from stimuli that shouldn't be painful like light touch or moderate pressure, the central sensitization process is well established and self-sustaining. Ketamine's NMDA receptor blockade directly interrupts this process, offering the most mechanistically appropriate intervention available for this presentation.
Your Fibromyalgia Treatment Journey at Relevate Ketafusion
From your first conversation to your last session, we're with you at every step.
01
Initial Consultation
Your journey starts with a virtual consultation. We'll talk through your fibromyalgia history, the character and distribution of your pain, your co-occurring conditions, the treatments you've tried, and your goals. Dr. Schumaker will assess whether IV ketamine, Spravato, or a combination is the most appropriate approach for your specific presentation. We'll set honest, realistic expectations from the start.
02
Personalized Treatment Plan
Fibromyalgia protocols are individualized to your presentation and response. We'll map out your recommended number of sessions, infusion parameters, and timeline, and discuss how ketamine therapy fits alongside your existing treatment approach. We'll also coordinate with your other providers where appropriate to ensure a cohesive plan.
03
Treatment Sessions
Every session takes place in a private, calm treatment room with ambient lighting and soothing music. Our medical team stays present throughout, monitoring your vitals and your comfort in real time. Most patients describe the experience as peaceful. Plan to have someone drive you home afterward and allow adequate rest time following each session.
04
Monitoring and Maintenance
We track your pain response, fatigue levels, and overall wellbeing carefully across your initial series and adjust the plan as needed. The duration of pain relief following ketamine treatment varies by patient. Maintenance infusion schedules are built around your individual response, aiming for the longest possible period of meaningful relief with the least frequent treatment necessary.
Our Fibromyalgia Treatment: IV Ketamine and Spravato
We offer two clinically relevant treatments for fibromyalgia and its co-occurring conditions. Your provider will help determine the right fit based on your pain presentation, co-occurring conditions, and goals.
IV Ketamine Therapy
Administered directly into the bloodstream through a small IV line, ketamine infusions provide precise dosing and immediate effect. For fibromyalgia, infusion protocols are calibrated for central pain modulation, which may differ from standard mental health protocols in duration and dosing. Sessions are conducted in a private, calm treatment room with continuous medical supervision. IV ketamine is self-pay and not covered by insurance. Pricing for extended pain infusions differs from standard session pricing.
Learn More
Spravato (Esketamine) Therapy
FDA-approved for treatment-resistant depression and MDD with suicidal ideation, Spravato is particularly relevant for fibromyalgia patients who also carry significant treatment-resistant depression. By addressing the depression component through a different pathway than standard antidepressants, Spravato can reduce the mood-related amplification of pain while providing its own analgesic benefit through glutamate modulation. Spravato is covered by most major insurance plans.
Learn More
The Science Behind Ketamine for Fibromyalgia
Fibromyalgia is now understood as a disorder of central pain amplification rather than a peripheral tissue or rheumatological problem. The central nervous system, particularly the spinal cord and brain, has become abnormally sensitized, producing pain responses to stimuli that wouldn’t be painful in someone without central sensitization. NMDA receptors are a key driver of this sensitization.
Ketamine’s potent NMDA receptor blockade directly interrupts the central sensitization process. By reducing NMDA receptor activity, ketamine lowers the pain system’s amplification gain, allowing the nervous system to respond to stimuli more normally. This is a mechanistically direct intervention: ketamine acts precisely on the receptor system most implicated in the neurological dysfunction driving fibromyalgia.
Beyond its direct pain mechanism, ketamine also promotes neuroplasticity and rapidly addresses depression and anxiety, both of which amplify fibromyalgia pain through shared neural pathways. The combination of pain relief, mood improvement, and neurological recalibration makes ketamine one of the most comprehensively relevant treatments available for fibromyalgia.
Why Choose Relevate Ketafusion for Fibromyalgia Treatment
01
We Take Fibromyalgia Seriously
Too many fibromyalgia patients have experienced dismissal, minimization, or outright disbelief from the healthcare system. Our team approaches fibromyalgia as the well-documented neurological condition it is. We don’t question your pain. We work to address its mechanism.
02
A Mechanistically Direct Intervention
FDA-approved fibromyalgia medications target serotonin, norepinephrine, or calcium channels, all of which influence central sensitization indirectly. Ketamine targets NMDA receptors, the most directly implicated mechanism in central sensitization, making it arguably the most mechanistically appropriate pharmacological intervention available for fibromyalgia.
03
Pain and Mood Addressed Together
Depression and anxiety aren’t separate problems to manage alongside fibromyalgia. They share the same neural pathways and actively amplify the pain. Ketamine addresses all three simultaneously, which no FDA-approved fibromyalgia medication can claim.
04
A Medical Director Who Understands Pain Science at the Molecular Level
Dr. Howard Schumaker’s dual board certifications in Family and Emergency Medicine combined with his chemical engineering background mean he understands ketamine’s mechanism of action in central pain modulation in exceptional depth. He personally oversees every fibromyalgia treatment protocol at Relevate.
05
The Only IV Ketamine Clinic in the Coulee Region
Relevate Ketafusion is the only provider in the La Crosse area offering IV ketamine infusions. The nearest alternative is over two hours away. For someone managing the fatigue and pain of fibromyalgia, that drive is a real barrier to care. We built this clinic so you wouldn’t have to make it.
06
Continuous Medical Supervision at Every Session
Every session happens under direct medical supervision with continuous vital sign monitoring. Our team adjusts in real time and stays present throughout every visit, ensuring both safety and optimal therapeutic effect.
Blogs
Insights & Resources
Explore articles that empower your path to wellness.
March 25, 2026
Hope Beyond Traditional Antidepressants: Exploring New Paths to Healing
March 18, 2026
The Role of Integration After Ketamine Sessions
March 11, 2026
Understanding Dissociation: Why Some People Experience It and How It Is Managed During Treatment